VANGUARD GROUP INC 13D and 13G filings for Regulus Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 4:45 pm Unchanged |
2024-09-30 | 13G | Regulus Therapeutics Inc. RGLS |
VANGUARD GROUP INC | 4,088,760 6.240% |
0 (Unchanged) |
Filing |
| 2024-11-04 1:46 pm Purchase |
2024-09-30 | 13G | Regulus Therapeutics Inc. RGLS |
VANGUARD GROUP INC | 4,088,760 6.240% |
4,088,760 (New Position) |
Filing |